IL1A and rheumatoid arthritis: IL-1Ra prevents the inflammation driven by either IL-1α and IL-1β, and is approved to treat rheumatoid arthritis for subcutaneous (s.c.)administration of 100 mg daily, but is widely used off-label (11).